POST Online Media Lite Edition


Biogen names EVP, pharmaceutical operations & technology

Staff writer |
Cambridge, Mass., USA - June 22, 2016, Cambridge, Mass., USA - Biogen, a biotechnology company, appoints Paul McKenzie as EVP, pharmaceutical operations & technology, effective July 1, 2016.

Dr. McKenzie was promoted from his previous position as senior vice president of Global Biologics Manufacturing and Technical Operations.

Dr. McKenzie joined Biogen in February from Johnson & Johnson, where he held a variety of leadership roles, most recently as vice president of R&D for J&J’s Ethicon business.

Prior to that role, Dr. McKenzie led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen’s pharmaceutical portfolio.

He also ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization.

Dr. McKenzie also held various R&D and manufacturing positions at Bristol-Myers Squibb and Merck.

Dr. McKenzie graduated from the University of Pennsylvania and received his doctorate in chemical engineering from Carnegie Mellon University.

LATEST 5 MOVES FROM Massachusetts 

What to read next

ShangPharma appoints president
Biogen Idec names chief strategy officer
The Medicines Company appoints Tony Kingsley as COO